Vivos Therapeutics (NASDAQ: VVOS) has announced an expanded strategic engagement with closely held Greenway Health, a leading healthcare technology company, to deploy Greenway’s new AI-by-design Novare platform across Vivos’ growing clinical operations.
According to Vivos, program implementation has already begun at Sleep Centers of Nevada (SCN). Following Greenway’s extensive analysis of operational data from SCN, Greenway estimates that implementation of their Novare and related workflow automation could potentially generate approximately $9.1 million of annual value creation for Vivos at SCN. In addition, Vivos estimates potential additional savings of up to $1.8 million annually at SCN from the estimated 46,000+ annual recovered labor hours.
In a statement, Richard Atkin, CEO of Greenway, commented, “Vivos is demonstrating what it means to lead with innovation by embracing our AI-by-design Novare platform to empower providers and support exceptional patient care. We’re proud to partner with an organization that shares our vision for the future of ambulatory healthcare. Together, we are reimagining workflows, reducing administrative burdens, and improving operational efficiencies to support Vivos’ continued growth.”
